Editorial overview – 2022 respiratory issue: Cystic fibrosis pathophysiology, models, and novel therapies

Carla M. P. Ribeiro, PhD, Dr. Ribeiro is a professor of medicine, a joint professor of physiology and cell biology, and a member of the Marsico Lung Institute and the Cystic Fibrosis Research Center at the University of North Carolina at Chapel Hill. She studies airway diseases characterized by inflammation, mucus obstruction, and oxidative stress, for example, cystic fibrosis (CF), asthma, and chronic obstructive pulmonary disease. The Ribeiro lab has developed key translational models for studying CF lung pathophysiology.

Martina Gentzsch, PhD, Dr. Gentzsch is an associate professor of pediatric pulmonology, an adjunct associate professor of cell biology and physiology, and member of the Marsico Lung Institute and the Cystic Fibrosis Research Center at the University of North Carolina at Chapel Hill. Her studies focus on restoring CFTR function in cystic fibrosis. She has developed bronchial, nasal, and intestinal models to examine the efficacy of CFTR therapeutics, and her research has been vital to understanding the trafficking, processing, and regulation of CFTR.

© 2022 Published by Elsevier Ltd.

留言 (0)

沒有登入
gif